These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10116351)

  • 1. Pryor bill to enter fray over drug costs.
    Weissenstein E
    Mod Healthc; 1992 Mar; 22(9):26. PubMed ID: 10116351
    [No Abstract]   [Full Text] [Related]  

  • 2. Bill seeking to cut drugmaker tax breaks defeated in Senate.
    Wagner L
    Mod Healthc; 1992 Mar; 22(11):2-3. PubMed ID: 10116801
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlling the cost of prescription drugs.
    White JR
    Health Prog; 1992 Mar; 73(2):12-4, 25. PubMed ID: 10116498
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies renew price-curb talk.
    Weissenstein E
    Mod Healthc; 1994 Feb; 24(6):17. PubMed ID: 10131519
    [No Abstract]   [Full Text] [Related]  

  • 5. These doctor's mission: keeping drug costs down.
    Guglielmo WJ
    Med Econ; 2001 Apr; 78(8):108-10, 113-6. PubMed ID: 11386066
    [No Abstract]   [Full Text] [Related]  

  • 6. Senate proposal would reduce drug prices for federal agencies.
    Weissenstein E
    Mod Healthc; 1992 Aug; 22(33):20. PubMed ID: 10119805
    [No Abstract]   [Full Text] [Related]  

  • 7. Price controls for drugs.
    Rubin PH
    J Med Assoc Ga; 1995 Mar; 84(3):135-6. PubMed ID: 7738447
    [No Abstract]   [Full Text] [Related]  

  • 8. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices.
    Pinzone JD
    J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775
    [No Abstract]   [Full Text] [Related]  

  • 9. Opinion: price controls on prescription drugs.
    Franks B
    N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drug manufacturers get warning on prices.
    Margolis RE
    Healthspan; 1993 Mar; 10(3):19-20. PubMed ID: 10125344
    [No Abstract]   [Full Text] [Related]  

  • 11. The need for health care reform.
    Mossinghoff GJ
    Health Syst Rev; 1994; 27(3):5-6. PubMed ID: 10134516
    [No Abstract]   [Full Text] [Related]  

  • 12. The war on drug--prices: states are taking up the fight to reduce prescription drug costs.
    Boulard G
    State Legis; 2002 Mar; 28(3):12-7. PubMed ID: 11873811
    [No Abstract]   [Full Text] [Related]  

  • 13. Just roiling along.
    Tieman J
    Mod Healthc; 2000 Oct; 30(44):8-9. PubMed ID: 11141844
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmaceutical industry--to whom is it accountable?
    Holmer AF
    N Engl J Med; 2000 Nov; 343(19):1415; discussion 1417. PubMed ID: 11183877
    [No Abstract]   [Full Text] [Related]  

  • 15. Notice regarding Section 602 of the Veterans Health Care Act of 1992; new drug pricing--PHS. Final notice.
    Fed Regist; 1995 Oct; 60(190):51488-9. PubMed ID: 10151188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowering Part D drug costs without direct CMS negotiations.
    Sipkoff M
    Manag Care; 2009 Sep; 18(9):11-2. PubMed ID: 19886203
    [No Abstract]   [Full Text] [Related]  

  • 17. CMS retreats on Part D rule intended to reduce drug costs and improve access.
    Dickson V
    Mod Healthc; 2014 Mar; 44(11):10. PubMed ID: 24830094
    [No Abstract]   [Full Text] [Related]  

  • 18. How will drug and device makers fare under Clinton's reform plan?
    Blankenau R
    Mater Manag Health Care; 1993 Nov; 2(11):18, 20. PubMed ID: 10129563
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulating the pharmaceutical industry: who really benefits?
    Stano M
    Am J Manag Care; 2000 Jan; 6(1):29-31. PubMed ID: 11009744
    [No Abstract]   [Full Text] [Related]  

  • 20. The other drug lords.
    Novak V
    Int J Health Serv; 1993; 23(2):263-73. PubMed ID: 8500946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.